Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib may help treat severe hair loss, but more research is needed.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ketoconazole shampoo can cause rare pink hair discoloration.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Baricitinib shows promise in treating severe hair loss.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Systemic therapy is needed for deep hair follicle infections, and proper dosage is crucial for treatment success.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Prompt treatment of tinea capitis with oral antifungals leads to excellent recovery, but delayed care can cause permanent hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Microneedling with triamcinolone is a safe, effective, and less painful treatment for alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.